A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Cancer Etiology Bookmark and Share

Cancer Etiology

Examining the causes of cancer

The goal of the Division of Cancer Etiology is to understand the causes of cancer. This knowledge can enable scientists to develop solutions to help reduce cancer risk, especially in people who have the greatest likelihood of developing the disease.

Our researchers
Leslie Bernstein, Ph.D., director of the Division of Cancer Etiology

Among the most accomplished researchers working in cancer epidemiology today, Bernstein was instrumental in identifying physical activity as a means to reduce the risk of breast cancer. She is involved in projects to explore the links between hormone exposures, physical activity, obesity and cancer. She is also examining how breast cancer impacts the lives of women after they are finished with treatment.
 

Jessica Clague DeHart, Ph.D., M.P.H., assistant research professor
Clague DeHart is examining the genetic and molecular epidemiology of women’s cancers. Her focus is the biological mechanisms underlying associations between modifiable risk factors and cancer risk reduction and survival.

 

Katherine Henderson, Ph.D., assistant research professor
 

James V. Lacey Jr., Ph.D., associate professor
Lacey’s work has been key in demonstrating that women using menopausal progestins and estrogens are more likely to develop uterine and ovarian cancer. He is continuing to investigate how hormones affect the risk of developing uterine cancer, ovarian cancer, breast cancer and other diseases among women. He is leading the expansion of the California Teachers Study.
 
Yani Lu, M.D., Ph.D., assistant research professor
Lu’s research involves breast cancer, blood cancer and other types of cancer, with a focus on etiology and survival.
 
Huiyan Ma, Ph.D., assistant research professor
The lead manager of the databases that constitute the California Teachers Study, she studies the epidemiology of women’s cancers.  Her primary focuses include understanding the roles of alternative and complementary medicine among breast cancer survivors and identifying the risk factors for different subtypes of breast cancer.

 

Susan L. Neuhausen, Ph.D., Morris and Horowitz Families Professor in Cancer Etiology and Outcomes Research
Neuhausen’s research is on identifying environmental and genetic stressors that predispose people to disease, focusing primarily on ovarian and breast cancers and celiac disease. She is working to understand why some individuals are more prone to develop certain illnesses, thus allowing the design and implementation of programs to keep those people healthy.

 

Sophia S. Wang, Ph.D., associate professor
Wang has focused on epidemiological research in cervical cancer and non-Hodgkin lymphoma and understanding the molecular and genetic contributions to cancer causation. She seeks to understand the role of immunity and inflammation in cancers among women. She is also expanding the scope of her research to other chronic diseases for which disease burdens disproportionately affect women.
 
Research Highlights
California Teachers Study
 
In 1995 and 1996, 133,479 female teachers and public school professionals in California responded to a request to participate in a large prospective cohort study. Since then, those women have offered information about their lifestyles, health and backgrounds through mailed questionnaires, and some have given biological samples. This huge cache of data has allowed researchers to determine what differentiates the women who have developed cancer from those who have not.
 
Some of the most recent findings from the California Teacher Study include:
 
  • obesity is related to an increased risk of pancreatic cancer
  • small particulate air pollution is related to the risk of cardiovascular disease deaths
  • smoking and secondhand smoke may increase the risk of non-Hodgkin lymphoma
  • delayed onset of puberty may be related to an increased risk of thyroid cancer in younger women
  • a decrease in invasive breast cancer is explained in large part by the decline in use of hormone therapy to treat menopausal symptoms. 
 
Now, in an expansion of the California Teacher Study, researchers are collecting blood and saliva samples from more than 20,000 cohort members with no history of any cancer. This large group of biospecimens, along with data on diet, lifestyle and other factors, will help researchers identify new biomarkers for early detection, predict responses to treatments, and identify genetic and environmental interactions. This new information could lead to better treatments and perhaps prevention of cancer.
 
 

Cancer Etiology

Cancer Etiology

Examining the causes of cancer

The goal of the Division of Cancer Etiology is to understand the causes of cancer. This knowledge can enable scientists to develop solutions to help reduce cancer risk, especially in people who have the greatest likelihood of developing the disease.

Our researchers
Leslie Bernstein, Ph.D., director of the Division of Cancer Etiology

Among the most accomplished researchers working in cancer epidemiology today, Bernstein was instrumental in identifying physical activity as a means to reduce the risk of breast cancer. She is involved in projects to explore the links between hormone exposures, physical activity, obesity and cancer. She is also examining how breast cancer impacts the lives of women after they are finished with treatment.
 

Jessica Clague DeHart, Ph.D., M.P.H., assistant research professor
Clague DeHart is examining the genetic and molecular epidemiology of women’s cancers. Her focus is the biological mechanisms underlying associations between modifiable risk factors and cancer risk reduction and survival.

 

Katherine Henderson, Ph.D., assistant research professor
 

James V. Lacey Jr., Ph.D., associate professor
Lacey’s work has been key in demonstrating that women using menopausal progestins and estrogens are more likely to develop uterine and ovarian cancer. He is continuing to investigate how hormones affect the risk of developing uterine cancer, ovarian cancer, breast cancer and other diseases among women. He is leading the expansion of the California Teachers Study.
 
Yani Lu, M.D., Ph.D., assistant research professor
Lu’s research involves breast cancer, blood cancer and other types of cancer, with a focus on etiology and survival.
 
Huiyan Ma, Ph.D., assistant research professor
The lead manager of the databases that constitute the California Teachers Study, she studies the epidemiology of women’s cancers.  Her primary focuses include understanding the roles of alternative and complementary medicine among breast cancer survivors and identifying the risk factors for different subtypes of breast cancer.

 

Susan L. Neuhausen, Ph.D., Morris and Horowitz Families Professor in Cancer Etiology and Outcomes Research
Neuhausen’s research is on identifying environmental and genetic stressors that predispose people to disease, focusing primarily on ovarian and breast cancers and celiac disease. She is working to understand why some individuals are more prone to develop certain illnesses, thus allowing the design and implementation of programs to keep those people healthy.

 

Sophia S. Wang, Ph.D., associate professor
Wang has focused on epidemiological research in cervical cancer and non-Hodgkin lymphoma and understanding the molecular and genetic contributions to cancer causation. She seeks to understand the role of immunity and inflammation in cancers among women. She is also expanding the scope of her research to other chronic diseases for which disease burdens disproportionately affect women.
 
Research Highlights
California Teachers Study
 
In 1995 and 1996, 133,479 female teachers and public school professionals in California responded to a request to participate in a large prospective cohort study. Since then, those women have offered information about their lifestyles, health and backgrounds through mailed questionnaires, and some have given biological samples. This huge cache of data has allowed researchers to determine what differentiates the women who have developed cancer from those who have not.
 
Some of the most recent findings from the California Teacher Study include:
 
  • obesity is related to an increased risk of pancreatic cancer
  • small particulate air pollution is related to the risk of cardiovascular disease deaths
  • smoking and secondhand smoke may increase the risk of non-Hodgkin lymphoma
  • delayed onset of puberty may be related to an increased risk of thyroid cancer in younger women
  • a decrease in invasive breast cancer is explained in large part by the decline in use of hormone therapy to treat menopausal symptoms. 
 
Now, in an expansion of the California Teacher Study, researchers are collecting blood and saliva samples from more than 20,000 cohort members with no history of any cancer. This large group of biospecimens, along with data on diet, lifestyle and other factors, will help researchers identify new biomarkers for early detection, predict responses to treatments, and identify genetic and environmental interactions. This new information could lead to better treatments and perhaps prevention of cancer.
 
 
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education.
 
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti
800-888-5323
dgrignetti@coh.org

 

For sponsorships inquiries please contact:

Stefanie Sprester
213-241-7160
ssprester@coh.org

Christine Nassr
213-241-7112
cnassr@coh.org

 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 
NEWS & UPDATES
  • Although chemotherapy can be effective in treating cancer, it can also exact a heavy toll on a patient’s health. One impressive alternative researchers have found is in the form of a vaccine. A type of immunotherapy, one part of the vaccine primes the body to react strongly against a tumor; the second part dire...
  • The breast cancer statistic is attention-getting: One in eight women will be diagnosed with breast cancer during her lifetime. That doesn’t mean that, if you’re one of eight women at a dinner table, one of you is fated to have breast cancer (read more on that breast cancer statistic), but it does mean that the ...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. In his first post, ...
  • Advanced age tops the list among breast cancer risk factor for women. Not far behind is family history and genetics. Two City of Hope researchers delving deep into these issues recently received important grants to advance their studies. Arti Hurria, M.D., director of the Cancer and Aging Research Program, and ...
  • City of Hope is extending the reach of its lifesaving mission well beyond U.S. borders. To that end, three distinguished City of Hope leaders visited China earlier this year to lay the foundation for the institution’s new International Medicine Program. The program is part of City of Hope’s strategi...
  • A hallmark of cancer is that it doesn’t always limit itself to a primary location. It spreads. Breast cancer and lung cancer in particular are prone to spread, or metastasize, to the brain. Often the brain metastasis isn’t discovered until years after the initial diagnosis, just when patients were beginning to ...
  • Blueberries, cinnamon, baikal scullcap, grape seed extract (and grape skin extract), mushrooms, barberry, pomegranates … all contain compounds with the potential to treat, or prevent, cancer. Scientists at City of Hope have found tantalizing evidence of this potential and are determined to explore it to t...
  • Most women who are treated for breast cancer with a mastectomy do not choose to undergo reconstructive surgery. The reasons for this, according to a recent JAMA Surgery study, vary. Nearly half say they do not want any additional surgery, while nearly 34 percent say breast cancer reconstruction simply isn’t imp...
  • The leading risk factor for breast cancer is simply being a woman. The second top risk factor is getting older. Obviously, these two factors cannot be controlled, which is why all women should be aware of their risk and how to minimize those risks. Many risk factors can be mitigated, and simple changes can lead...
  • All women are at some risk of developing the disease in their lifetimes, but breast cancer, like other cancers, has a disproportionate effect on minorities. Although white women have the highest incidence of breast cancer, African-American women have the highest breast cancer death rates of all racial and ethni...
  • First, the good news: HIV infections have dropped dramatically over the past 30 years. Doctors, researchers and health officials have made great strides in preventing and treating the disease, turning what was once a death sentence into, for some, a chronic condition. Now, the reality check: HIV is still a worl...
  • Screening for breast cancer has dramatically increased the number of cancers found before they cause symptoms – catching the disease when it is most treatable and curable. Mammograms, however, are not infallible. It’s important to conduct self-exams, and know the signs and symptoms that should be checked by a h...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free.   In his previ...
  • In a single day, former professional triathlete Lisa Birk learned she couldn’t have children and that she had breast cancer. “Where do you go from there?” she asks. For Birk, who swims three miles, runs 10 miles and cycles every day, the answer  ultimately was a decision to take control of her cancer care. Afte...
  • More and more people are surviving cancer, thanks to advanced cancer treatments and screening tools. Today there are nearly 14.5 million cancer survivors in the United States. But in up to 20 percent of cancer patients, the disease ultimately spreads to their brain. Each year, nearly 170,000 new cases of brain ...